Sugammadex Injection, Solution
Product Images NDC 76045-219

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 76045-219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sug01 0004 01)

An instructional diagram showing the components of a syringe containing sugammadex injection solution. Labeled parts include the plunger rod, syringe barrel with a label ('Do not remove'), luer lock collar, and syringe tip cap. The syringe is shown both inside the outer package and separately to highlight these parts.*

FDA Label Image

Figure 2 (Sug01 0004 02)

An instructional illustration depicts two hands peeling open a foil pouch containing a prefilled syringe, demonstrating safe packaging opening procedure for an injectable solution.*

FDA Label Image

Figure 3 (Sug01 0004 03)

An instructional black-and-white line drawing showing hands removing a cap from a vial or similar container by twisting. An arrow indicates the direction to turn the cap for removal. The image is likely part of a medication preparation or administration guide.*

FDA Label Image

Structural Formula (Sug01 0004 04)

Chemical structure of sugammadex, depicting its molecular arrangement with multiple sodium carboxylate groups and sulfur-containing components forming a cyclic structure.*

FDA Label Image

Structural Formula (Sug01 0004 05)

Chemical structure diagram of sugammadex, showing its molecular arrangement with multiple sugar rings and sodium carboxylate groups as labeled in the structure.*

FDA Label Image

Figure 1 (Sug01 0004 06)

A line graph depicting cumulative recovery rate over time (minutes) comparing recovery times for sugammadex at 2 mg/kg, neostigmine at 0.05 mg/kg, and rocuronium. The graph shows faster recovery with sugammadex. Median recovery times with quartile values are included in an inset box.*

FDA Label Image

Figure 2 (Sug01 0004 07)

A Kaplan-Meier curve chart showing cumulative recovery rate over time in minutes comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg following vecuronium administration. The graph includes median recovery times with quartile ranges for both drugs, indicating faster recovery with sugammadex.*

FDA Label Image

Fresenius Kabi (Sug01 0004 08)

FDA Label Image

Package Label – Principal Display Panel – Sugammadex 2 mL Single-dose Syringe Label (Sug01 0004 09)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) single-dose vial by Fresenius Kabi USA, LLC. The label shows a 2 mL capacity scale, indicates use is intravenous (IV) only, and includes a barcode and RFID symbol. The product is prescription only.*

FDA Label Image

Package Label – Principal Display Panel – Sugammadex 2 mL Single-dose Blister Label (Sug01 0004 10)

Label for Sugammadex Injection 200 mg per 2 mL (100 mg/mL) from Fresenius Kabi USA, LLC. The label indicates a 2 mL single-dose prefilled syringe, for intravenous use only. Storage instructions specify 25°C (77°F) with allowable excursions, protection from light, and not placing the syringe on a sterile field. Expiration and lot number areas are blank.*

FDA Label Image

Package Label – Principal Display Panel – Sugammadex 2 mL Single-dose Carton Label (Sug01 0004 11)

Packaging label for Sugammadex Injection 200 mg per 2 mL (100 mg/mL) solution for intravenous use. The label displays dosage information, storage instructions, and warnings. The product is supplied in prefilled syringes, labeled by Fresenius Kabi USA, LLC, with NDC 76045-219. The box includes regulatory and bar code details consistent with FDA requirements.*

FDA Label Image

Package Label – Principal Display Panel – Sugammadex 2 mL Single-dose Syringe Label (Sug01 0004 12)

Label of Sugammadex Injection 200 mg per 2 mL (100 mg/mL) solution for intravenous use. The label specifies a 2 mL single-dose vial and includes a volume measurement scale from 0.5 mL to 2 mL. The product is labeled as prescription-only and the labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label – Principal Display Panel – Sugammadex 2 mL Single-dose Blister Label (Sug01 0004 13)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) in a 2 mL single-dose prefilled syringe. The label includes storage instructions (25°C with permitted excursions), warnings against placing the syringe on sterile fields, and a barcode. The product is labeled for intravenous use and provided by Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label – Principal Display Panel – Sugammadex 2 mL Single-dose Carton Label (Sug01 0004 14)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous solution by Fresenius Kabi USA, LLC. The label includes dosage instructions, storage information, and warnings. It indicates the product comes in a box containing 24 single-dose prefilled syringes, each 2 mL volume.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.